Capital Fund Management (CFM)’s Vertex Pharmaceuticals VRTX Stock Holding History

Capital Fund Management (CFM)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,500	Closed	-$5.35M	–	2269
2024 Q3	$5.35M	Buy	+11,500	New	+$5.52M	0.01%	990
2024 Q2	–	Sell	-13,500	Closed	-$5.64M	–	2194
2024 Q1	$5.64M	Buy	+13,500	New	+$5.71M	0.02%	995
2023 Q4	–	Sell	-41,300	Closed	-$14.4M	–	2313
2023 Q3	$14.4M	Buy	+41,300	New	+$14.4M	0.05%	472
2020 Q2	–	Sell	-6,500	Closed	-$1.55M	–	1602
2020 Q1	$1.55M	Buy	+6,500	New	+$1.49M	0.02%	608
2018 Q1	–	Sell	-2,500	Closed	-$375K	–	2206
2017 Q4	$375K	Sell	2,500 -2,200	-47%	-$326K	﹤0.01%	1552
2017 Q3	$715K	Buy	+4,700	New	+$707K	0.01%	1077
2014 Q4	–	Sell	-1,800	Closed	-$202K	–	1825
2014 Q3	$202K	Buy	+1,800	New	+$171K	﹤0.01%	1455
2013 Q3	–	Sell	-33,300	Closed	-$2.66M	–	1925
2013 Q2	$2.66M	Buy	+33,300	New	+$2.45M	0.04%	543

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Fund Management (CFM)'s VRTX Position: Q1 2026 in Review

Capital Fund Management (CFM) opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 122,934 shares worth $54.9M. The stake represents 0.25% of the portfolio and ranks #63 among its holdings. This is a return to the name: Capital Fund Management (CFM) previously reported a position in VRTX as recently as Q1 2024.

Capital Fund Management (CFM) first reported a position in VRTX in Q2 2013 and has held it in 24 quarters since. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Capital Fund Management (CFM) held 122,934 shares of Vertex Pharmaceuticals worth $54.9M as of Q1 2026.
Vertex Pharmaceuticals was a new Capital Fund Management (CFM) position in Q1 2026.
Vertex Pharmaceuticals made up 0.25% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #63 holding.
Capital Fund Management (CFM) first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 24 quarters since.
1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.